CSIMarket
 


Htg Molecular Diagnostics Inc  (HTGM)
Other Ticker:  
 
 

HTGM's Revenue Growth by Quarter and Year

Htg Molecular Diagnostics Inc's Revenue results by quarter and year




HTGM Revenue (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December - 2.44 2.88 2.58
III Quarter September - 1.25 2.52 1.78
II Quarter June - 1.49 2.07 1.96
I Quarter March 1.03 1.18 1.44 2.23
FY   1.03 6.36 8.91 8.55



HTGM Revenue first quarter 2023 Y/Y Growth Comment
Htg Molecular Diagnostics Inc reported fall in Revenue in the first quarter 2023 by -12.5% to $ 1.03 millions, from the same quarter in 2022.
The decline in the first quarter 2023 Htg Molecular Diagnostics Inc's Revenue compares unfavorably to the Company's average Revenue rise of 34.6%.

Looking into first quarter 2023 results within Laboratory Analytical Instruments industry 22 other companies have achieved higher Revenue growth. While Htg Molecular Diagnostics Inc' s Revenue decrease of -12.5% ranks overall at the positon no. 3269 in the first quarter 2023.




HTGM Revenue ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - -15.28 % 11.63 % -46.25 %
III Quarter September - -50.4 % 41.57 % -67.04 %
II Quarter June - -28.02 % 5.61 % -66.21 %
I Quarter March -12.5 % -18.06 % -35.43 % -30.31 %
FY   - -28.62 % 4.21 % -55.47 %

Financial Statements
Htg Molecular Diagnostics Inc's first quarter 2023 Revenue $ 1.03 millions HTGM's Income Statement
Htg Molecular Diagnostics Inc's first quarter 2022 Revenue $ 1.18 millions Quarterly HTGM's Income Statement
New: More HTGM's historic Revenue Growth >>


HTGM Revenue (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - 95.2 % 14.29 % 44.94 %
III Quarter September - -16.11 % 21.74 % -9.18 %
II Quarter June - 26.27 % 43.75 % -12.11 %
I Quarter March -57.68 % -59.03 % -44.19 % -53.54 %
FY (Year on Year)   - -28.62 % 4.21 % -55.47 %




Revenue first quarter 2023 Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #23
Healthcare Sector #505
Overall #3269

Revenue Y/Y Growth Statistics
High Average Low
442.2 % 34.6 % -67.12 %
(Dec 31 2017)   (Sep 30 2020)
Revenue first quarter 2023 Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #23
Healthcare Sector #505
Overall #3269
Revenue Y/Y Growth Statistics
High Average Low
442.2 % 34.6 % -67.12 %
(Dec 31 2017)   (Sep 30 2020)

Revenue by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Htg Molecular Diagnostics Inc's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
119.11 % 12.48 % -58.83 %
(Jun 30 2016)  


HTGM's I. Quarter Q/Q Revenue Comment
In the I. Quarter 2023 Htg Molecular Diagnostics Inc reported fall in Revenue sequentially by -57.68% to $ 1.03 millions, from $ 2.44 millions released in the previous reporting period.

It's not huge issue, as Htg Molecular Diagnostics Inc's Revenue generally seem to slow in the I. Quarter.

Within Laboratory Analytical Instruments industry 127 other companies have achieved higher Revenue quarter on quarter growth. While Htg Molecular Diagnostics Inc's Revenue growth quarter on quarter, overall rank is 3272.


Revenue Q/Q Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #128
Healthcare Sector #557
Overall #3272
Revenue Q/Q Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #128
Healthcare Sector #557
Overall #3272
Revenue Q/Q Growth Statistics
High Average Low
119.11 % 12.48 % -58.83 %
(Jun 30 2016)  


HTGM's I. Quarter Q/Q Revenue Comment
In the I. Quarter 2023 Htg Molecular Diagnostics Inc disclosed fall in Revenue sequentially by -57.68% to $ 1.03 millions, from $ 2.44 millions achived a quarter before.

When you analyse recent downturn at the I. Quarter, you should take into consideration, that commonly I. Quarter 2023 results emerge sluggish then in the quarter before, Esme  Davies, an industry contributor mentioned.

Within Laboratory Analytical Instruments industry 127 other companies have achieved higher Revenue quarter on quarter growth. While Htg Molecular Diagnostics Inc's Revenue growth quarter on quarter, overall rank is 3272.


Htg Molecular Diagnostics Inc's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
12 Months Ending
(Sep 30 2022)
12 Months Ending
(Jun 30 2022)
12 Months Ending
(Mar 31 2022)
Cumulative Revenue 12 Months Ending $ 6.21 $ 6.37 $ 6.80 $ 8.07 $ 8.66
Y / Y Revenue Growth (TTM) -28.21 % -28.52 % -21 % 2.59 % 11.57 %
Year on Year Revenue Growth Overall Ranking # 1665 # 2060 # 2341 # 2301 # 1804
Seqeuential Revenue Change (TTM) -2.39 % -6.43 % -15.72 % -6.73 % -2.81 %
Seq. Revenue Growth (TTM) Overall Ranking # 2833 # 2126 # 2687 # 3430 # 2690




Cumulative Revenue growth Comment
Htg Molecular Diagnostics Inc showed decline, but improvement compare to trailing twelve month Revenue decrease in Dec 31 2022. If the fiscal year would end in Mar 31 2023, Htg Molecular Diagnostics Inc's annual Revenue decline would be -28.21% year on year to $6 millions.

In the Healthcare sector 259 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 1665, from total ranking in previous quarter at 2060.

Revenue TTM Q/Q Growth Statistics
High Average Low
276.06 %
27.41 %
-57.43 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 20
Healthcare Sector # 260
Overall # 1665

Revenue TTM Y/Y Growth Statistics
High Average Low
276.06 %
27.41 %
-57.43 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 20
Sector # 402
S&P 500 # 2833
Cumulative Revenue growth Comment
Htg Molecular Diagnostics Inc showed decline, but improvement compare to trailing twelve month Revenue decrease in Dec 31 2022. If the fiscal year would end in Mar 31 2023, Htg Molecular Diagnostics Inc's annual Revenue drop would be -28.21% year on year to $6 millions.

In the Healthcare sector 259 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 1665, from total ranking in previous quarter at 2060.

Revenue TTM Q/Q Growth Statistics
High Average Low
276.06 %
27.41 %
-57.43 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 20
Healthcare Sector # 260
Overall # 1665

Revenue TTM Y/Y Growth Statistics
High Average Low
276.06 %
27.41 %
-57.43 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 20
Sector # 402
S&P 500 # 2833




Other Revenue Growth
Laboratory Analytical Instruments Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
HTGM's Revenue Growth Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for HTGM's Competitors
Revenue Growth for Htg Molecular Diagnostics Inc's Suppliers
Revenue Growth for HTGM's Customers

You may also want to know
HTGM's Annual Growth Rates HTGM's Profitability Ratios HTGM's Asset Turnover Ratio HTGM's Dividend Growth
HTGM's Roe HTGM's Valuation Ratios HTGM's Financial Strength Ratios HTGM's Dividend Payout Ratio
HTGM's Roa HTGM's Inventory Turnover Ratio HTGM's Growth Rates HTGM's Dividend Comparisons



Companies with similar Revenue drop for the quarter ending Mar 31 2023 within Healthcare SectorY/Y Change %Revenue for the quarter ending Mar 31 2023
Regenerx Biopharmaceuticals inc -0.01%$ -0.005 millions
Community Health Systems Inc -0.10%$ -0.096 millions
West Pharmaceutical Services Inc -0.47%$ -0.472 millions
Avalon Globocare Corp -0.49%$ -0.493 millions
Qhslab Inc -0.71%$ -0.712 millions
Dariohealth Corp -0.86%$ -0.856 millions
Acorda Therapeutics Inc -1.22%$ -1.225 millions
Baxter International Inc -1.56%$ -1.565 millions
Kymera Therapeutics Inc -1.62%$ -1.621 millions
Nature s Sunshine Products inc -1.68%$ -1.683 millions
Organon and Co -1.85%$ -1.851 millions
Scientific Industries Inc -2.08%$ -2.077 millions
Amgen Inc -2.13%$ -2.132 millions
Healthcare Services Group Inc -2.24%$ -2.245 millions
Orgenesis Inc -2.33%$ -2.329 millions
Adaptive Biotechnologies Corporation-2.52%$ -2.519 millions
Bristol myers Squibb Company-2.67%$ -2.670 millions
Caredx Inc -2.71%$ -2.712 millions
Biogen Inc -2.72%$ -2.717 millions
Innovage Holding Corp -2.72%$ -2.718 millions
Cardiff Lexington Corporation-2.73%$ -2.727 millions
Apyx Medical Corporation-2.81%$ -2.810 millions
Avanos Medical Inc -2.89%$ -2.888 millions
Align Technology inc -3.09%$ -3.090 millions
Laboratory Corporation Of America Holdings-3.12%$ -3.121 millions
Bio rad Laboratories Inc -3.32%$ -3.317 millions
National Healthcare Corp-3.38%$ -3.377 millions
Thermogenesis Holdings Inc -3.42%$ -3.417 millions
Gilead Sciences Inc -3.61%$ -3.612 millions
Arrowhead Pharmaceuticals Inc -3.65%$ -3.648 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com